Compounds > n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide
Page last updated: 2024-09-05

n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide and Poliomyelitis

n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide has been researched along with Poliomyelitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LOPEZCLARES, F1

Other Studies

1 other study(ies) available for n-(1-oxyl-2,2,5,5-tetramethyl-3-pyrrolidinyl)maleimide and Poliomyelitis

ArticleYear
[CLINICAL AND LABORATORY STUDY OF VARIOUS TYPES OF INFANTILE PARALYSIS IN MEXICO. II. THE MOST IMPORTANT CLINICAL CHARACTERISTICS OF PARALYSIS CASES CONFINED TO THE CONTAGIOUS DISEASE WARD 3 OF THE HOSPITAL INFANTIL DE M'EXICO DURING 1962].
    Gaceta medica de Mexico, 1964, Volume: 94

    Topics: Adolescent; Child; Cyclic N-Oxides; Hospitals; Humans; Infant; Infant, Newborn; Mexico; Paralysis; Poliomyelitis; Statistics as Topic

1964